PVLA compared with ARQT: revenue, margins and what each company keeps, and the suppliers and customers both name

PVLAPalvella Therapeutics, Inc.

Mkt capRevenueRevenue

ARQTArcutis Biotherapeutics, Inc.

Mkt capRevenueRevenue

Compare

PVLAPalvella Therapeutics, Inc.

ARQTArcutis Biotherapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Co-movers

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Co-movers

daily closes · 459dMethod ›

Moved together

PVLAwithARQT

×0.24co-movement · ARQT on PVLA · 459d

r 0.32scale to r 0.75

Shared co-movers4with PVLAwith ARQT

BEAMBeam Therapeutics Inc.r 0.37r 0.38

NRIXNurix Therapeutics, Inc.r 0.33r 0.38

XNCRXencor Incr 0.32r 0.40

INDVIndivior Pharmaceuticals, Inc.r 0.32r 0.53

PVLA, solidARQT, hatched× = co-movement · βr = correlationBar = r to r 0.75Order: weaker of A and BSource: daily closes

PVLAPalvella Therapeutics, Inc.

154.50▼−1.50%

Mkt cap—Revenue—Revenue—

ARQTArcutis Biotherapeutics, Inc.

26.91▼−0.33%

Regular sessionNov 6 '26

Mkt cap$3.4BRevenue$144MQ3 FY26Revenue$376MFY25

Compare

Regular sessionNov 6 '26

PVLAPalvella Therapeutics, Inc.

ARQTArcutis Biotherapeutics, Inc.

154.50▼−1.50%

Price

26.91▼−0.33%

—

Mkt cap

$3.4B

—

Revenue

$144MQ3 FY26

—

Revenue

$376MFY25

PVLA154.50▼−1.50%vsARQT26.91▼−0.33%Regular sessionNov 6 '26